gemfibrozil has been researched along with Liver Diseases in 3 studies
Liver Diseases: Pathological processes of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An increased risk for adverse events was observed with gemfibrozil relative to fenofibrate, predominantly driven by an increased rate of rhabdomyolysis." | 3.72 | Risk of adverse events with fibrates. ( Alsheikh-Ali, AA; Karas, RH; Kuvin, JT, 2004) |
| " We reviewed gemfibrozil- and fenofibrate-associated adverse event reports (AERs) submitted to the US Food and Drug Administration over a 5-year period." | 1.35 | Relative safety of gemfibrozil and fenofibrate in the absence of concomitant cerivastatin use. ( Alsheikh-Ali, AA; Holoshitz, N; Karas, RH, 2008) |
| "Gemfibrozil was determined in plasma and urine by means of a HPLC method." | 1.28 | Gemfibrozil absorption and elimination in kidney and liver disease. ( Knauf, H; Kölle, EU; Mutschler, E, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alsheikh-Ali, AA | 2 |
| Kuvin, JT | 1 |
| Karas, RH | 2 |
| Holoshitz, N | 1 |
| Knauf, H | 1 |
| Kölle, EU | 1 |
| Mutschler, E | 1 |
3 other studies available for gemfibrozil and Liver Diseases
| Article | Year |
|---|---|
Risk of adverse events with fibrates.
Topics: Aged; Chemical and Drug Induced Liver Injury; Female; Fenofibrate; Gemfibrozil; Humans; Hyperlipidem | 2004 |
Relative safety of gemfibrozil and fenofibrate in the absence of concomitant cerivastatin use.
Topics: Adverse Drug Reaction Reporting Systems; Chemical and Drug Induced Liver Injury; Databases, Factual; | 2008 |
Gemfibrozil absorption and elimination in kidney and liver disease.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Female; Gemfibrozil; Half-Life; Humans; Intestina | 1990 |